Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05999032 · ClinicalTrials.gov registry record · NA

The Puerto Rico Asthma Integrated Response Program ("PR-AIR")

A NA study of Pediatric Asthma, sponsored by Rhode Island Hospital.

Recruiting
Registry status
NA
Development phase
480
Enrollment target
2
Study locations

NCT05999032 is a NA study of Pediatric Asthma that is actively recruiting participants, run by Rhode Island Hospital. The registered enrollment target is 480 participants, below the 7,662-participant average among 9 other Pediatric Asthma trials with a reported enrollment target (94% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05999032, a NA study of Pediatric Asthma, is actively recruiting participants, sponsored by Rhode Island Hospital.

RECRUITING
Registry status
NA
Development phase
480 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this study is to adapt and deliver an evidence-based multi-level intervention to reduce asthma disparities, and that promote and improve population health in the high-burden communities of San Juan, Puerto Rico. The Puerto Rico-Asthma Integrated Response Program (PR-AIR) will be implemented and evaluated to address pediatric asthma disparities in San Juan, PR, an area of high asthma burden. This study unfolds in two phases: In Phase 1, the researchers will collaborate with community stakeholders to identify needs, barriers and facilitators of PR-AIR implementation. Phase 2 consists of an evaluation of low-intensity (virtual) and high-intensity (in-person) methods of PR-AIR implementation outcomes using the RE-AIM (Reach, Effectiveness, Adoption, Implementation, and Maintenance) framework and a mixed methods approach.

Conditions Studied

Interventions

  • BEHAVIORAL CASE in person version (High Intensity Package)
  • BEHAVIORAL CASE-V remote version (Low Intensity Package)
  • BEHAVIORAL CASE and HARP in person (High Intensity package)
  • BEHAVIORAL CASE-V and HARP-V remote version (Low Intensity package)

Study Locations (2)

Rhode Island

  • Rhode Island Hospital - Providence

Puerto Rico

  • Medial Sciences Campus, University of Puerto Rico - San Juan

Trial Details

FieldValue
Enrollment Target 480 participants
Start Date 2024-12-16
Est. Completion 2027-07-31
Phase NA

Sponsor

Rhode Island Hospital

130 total trials

What the Registry Record Tells You About NCT05999032

The ClinicalTrials.gov registry entry for NCT05999032 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 480 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 7,662-participant average among 9 other Pediatric Asthma trials with a reported enrollment target (94% lower). The listed sponsor is Rhode Island Hospital, which has 130 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pediatric Asthma appearing as the primary indexed condition, and to 4 interventions - of which CASE in person version (High Intensity Package) is the first listed.

NCT05999032 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Rhode Island, Puerto Rico.

Frequently Asked Questions

What is clinical trial NCT05999032 about?

NCT05999032 is a clinical study titled "The Puerto Rico Asthma Integrated Response Program ("PR-AIR")". The purpose of this study is to adapt and deliver an evidence-based multi-level intervention to reduce asthma disparities, and that promote and improve population health in the high-burden communities of San Juan, Puerto Rico. The Puerto Rico-Asthma Integrated Response Program (PR-AIR) will be impl...

What is the current status of trial NCT05999032?

This trial is currently recruiting. It is a NA study. The enrollment target is 480 participants. The study started on 2024-12-16. Estimated completion is 2027-07-31.

What conditions does trial NCT05999032 study?

This clinical trial studies the following conditions: Pediatric Asthma.

What interventions are being tested in trial NCT05999032?

The interventions under investigation include: CASE in person version (High Intensity Package) (BEHAVIORAL), CASE-V remote version (Low Intensity Package) (BEHAVIORAL), CASE and HARP in person (High Intensity package) (BEHAVIORAL), CASE-V and HARP-V remote version (Low Intensity package) (BEHAVIORAL).

Who is sponsoring clinical trial NCT05999032?

This trial is sponsored by Rhode Island Hospital, which has 130 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05999032 being conducted?

This trial has 2 study locations across Rhode Island, Puerto Rico. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pediatric Asthma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.